Rd. Dowling et al., Initial experience with the AbioCor implantable replacement heart at the University of Louisville, ASAIO J, 46(5), 2000, pp. 579-581
Potential benefits of heart transplantation are limited by the severe donor
organ shortage. The AbioCor implantable replacement heart has been develop
ed as a potential alternative to heart transplantation. We report our initi
al experience with the AbioCor in a bovine model. A right thoracotomy was p
erformed for access to the heart and great vessels. After initiation of car
diopulmonary bypass, excision of the native ventricles was followed by orth
otopic placement of the IRH and complete implantation of the transcutaneous
energy transfer coil, controller, and battery pack. Invasive monitoring of
IVC, SVC, carotid artery, pulmonary artery, and left atrial (LA) pressures
was performed in all animals. Twelve calves have undergone implantation of
the AbioCor. There were three early deaths, one from bleeding, one from re
spiratory failure, and one from neurodysfunction from low flow during CPB.
Nine animals have had a normal recovery and survived a mean of 24.5 days (r
ange, 4-48 days). All the animals have demonstrated excellent hemodynamics
with the maintenance of normal pressures in the LA, SVC, IVC, pulmonary art
ery, and aorta. Adjustment of the right-sided internal hydraulic fluid shun
t has allowed for control of right-left balance and, thereby, manipulation
of left and right side filling pressures. Late morbidity has consisted of n
eck wound infection and sepsis, pneumonia, and bleeding. Successful orthoto
pic implantation of all components of the AbioCor has been achieved in a bo
vine model. This device has demonstrated restoration of normal hemodynamics
and excellent function of the atrial hydraulic shunt to achieve right-left
balance.